Latest News and Press Releases

Autolus will report second quarter 2026 financial results on August 11, 2026.

Autolus announced preliminary second quarter 2026 AUCATZYL net product revenue that it has entered into a credit facility.

Autolus announced that the Compensation Committee of the Company's Board of Directors granted stock option awards.

Autolus will present at the H.C. Wainwright Cell Therapy Conference on June 30, 2026.

Autolus Therapeutics was awarded Prix Galien UK 2026 Best Biotechnology Product

Autolus will present and host meetings at two upcoming investor conferences.

Autolus announces the online publication of an abstract submitted to the American Society of Clinical Oncology (ASCO) Annual Meeting.

Autolus Therapeutics announced its operational and financial results for the first quarter ended March 31, 2026.

Autolus will report Q1 2026 financial results on May 14, 2026.

Autolus announced a strategic initiative and plan to improve operational efficiency and reduce operating expenses.